SpringWorks To Make Its Case For Nirogacestat At High-Stakes EMA Meeting

 
• By Francesca Bruce
  
Companies this week were scheduled to answer the case for EU marketing authorization for their products before the EMA. (Shutterstock)

More from Europe

More from Product Reviews